| Clinical, immunological, and genetic features in patients with activated PI3Kδ syndrome (APDS): a systematic review M Jamee, S Moniri, M Zaki-Dizaji, P Olbrich, R Yazdani, F Jadidi-Niaragh, ... Clinical Reviews in Allergy & Immunology 59, 323-333, 2020 | 128 | 2020 |
| Clinical, immunologic, and molecular spectrum of patients with LPS-responsive beige-like anchor protein deficiency: a systematic review S Habibi, M Zaki-Dizaji, H Rafiemanesh, B Lo, M Jamee, L Gámez-Díaz, ... The Journal of Allergy and Clinical Immunology: in Practice 7 (7), 2379-2386. e5, 2019 | 101 | 2019 |
| Synergistic effects of arsenic trioxide and silibinin on apoptosis and invasion in human glioblastoma U87MG cell line MZ Dizaji, M Malehmir, A Ghavamzadeh, K Alimoghaddam, SH Ghaffari Neurochemical research 37, 370-380, 2012 | 65 | 2012 |
| Clinical, immunological, and genetic features in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) and IPEX-like syndrome M Jamee, M Zaki-Dizaji, B Lo, H Abolhassani, F Aghamahdi, M Mosavian, ... The Journal of Allergy and Clinical Immunology: In Practice 8 (8), 2747-2760. e7, 2020 | 59 | 2020 |
| Alteration in miRNA gene expression pattern in acute promyelocytic leukemia cell induced by arsenic trioxide: a possible mechanism to explain arsenic multi-target action. AK Ghaffari SH, Bashash D, Dizaji MZ, Ghavamzadeh A Tumour Biol. 33 (1), 157-72, 2012 | 57* | 2012 |
| Arsenic trioxide induces apoptosis in NB-4, an acute promyelocytic leukemia cell line, through up-regulation of p73 via suppression of nuclear factor kappa B-mediated … M Momeny, M Zakidizaji, R Ghasemi, AR Dehpour, M Rahimi_Balaei, ... Medical Oncology 27, 833-842, 2010 | 56 | 2010 |
| Ataxia telangiectasia syndrome: moonlighting ATM M Zaki-Dizaji, SM Akrami, H Abolhassani, N Rezaei, A Aghamohammadi Expert Review of Clinical Immunology 13 (12), 1155-1172, 2017 | 55 | 2017 |
| Cellular and molecular mechanisms of immune dysregulation and autoimmunity G Azizi, MR Pouyani, H Abolhassani, L Sharifi, J Mohammadi, ... Cellular immunology 310, 14-26, 2016 | 54 | 2016 |
| Comprehensive comparison between 222 CTLA-4 haploinsufficiency and 212 LRBA deficiency patients: a systematic review M Jamee, S Hosseinzadeh, N Sharifinejad, M Zaki-Dizaji, M Matloubi, ... Clinical & Experimental Immunology 205 (1), 28-43, 2021 | 53 | 2021 |
| Inflammation, a significant player of Ataxia–Telangiectasia pathogenesis? M Zaki-Dizaji, SM Akrami, G Azizi, H Abolhassani, A Aghamohammadi Inflammation Research 67, 559-570, 2018 | 52 | 2018 |
| Silibinin inhibits invasive properties of human glioblastoma U87MG cells through suppression of cathepsin B and nuclear factor kappa B-mediated induction of matrix … M Momeny, M Malehmir, M Zakidizaji, R Ghasemi, H Ghadimi, ... Anti-cancer drugs 21 (3), 252-260, 2010 | 48 | 2010 |
| The use of immunoglobulin therapy in primary immunodeficiency diseases G Azizi, H Abolhassani, M Hosein Asgardoon, J Rahnavard, R Yazdani, ... Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2016 | 45 | 2016 |
| Genetic aspects of idiopathic asthenozoospermia as a cause of male infertility Z Heidary, K Saliminejad, M Zaki-Dizaji, HR Khorram Khorshid Human Fertility 23 (2), 83-92, 2020 | 40 | 2020 |
| Clinical, immunological, and genetic features in 49 patients with ZAP-70 deficiency: a systematic review N Sharifinejad, M Jamee, M Zaki-Dizaji, B Lo, M Shaghaghi, ... Frontiers in immunology 11, 831, 2020 | 39 | 2020 |
| MicroRNA profiling in spermatozoa of men with unexplained asthenozoospermia Z Heidary, M Zaki‐Dizaji, K Saliminejad, HR Khorram Khorshid Andrologia 51 (6), e13284, 2019 | 38 | 2019 |
| The clinical significance of complete class switching defect in Ataxia telangiectasia patients S Ghiasy, L Parvaneh, G Azizi, G Sadri, M Zaki dizaji, H Abolhassani, ... Expert review of clinical immunology 13 (5), 499-505, 2017 | 34 | 2017 |
| Molecular contribution of BRCA1 and BRCA2 to genome instability in breast cancer patients: Review of radiosensitivity assays F Sadeghi, M Asgari, M Matloubi, M Ranjbar, N Karkhaneh Yousefi, ... Biological procedures online 22, 1-28, 2020 | 32 | 2020 |
| IL-23 gene expression in PBMCs of patients with coronary artery disease M Khojasteh-Fard, M Abolhalaj, P Amiri, M Zaki, Z Taheri, M Qorbani, ... Disease Markers 33 (6), 289-293, 2012 | 31 | 2012 |
| Mendelian susceptibility to mycobacterial disease (MSMD): clinical and genetic features of 32 Iranian patients SA Mahdaviani, D Mansouri, M Jamee, M Zaki-Dizaji, KR Aghdam, ... Journal of clinical immunology 40, 872-882, 2020 | 30 | 2020 |
| Diagnostic approach to the patients with suspected primary immunodeficiency M Tavakol, M Jamee, G Azizi, H Sadri, Y Bagheri, M Zaki-Dizaji, ... Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2020 | 29 | 2020 |
